Works by Touw, Daan J.


Results: 122
    1
    2
    3
    4
    5
    6

    Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology – an analysis of the closed cohorts of a multicentre prospective study.

    Published in:
    British Journal of Cancer, 2024, v. 131, n. 5, p. 843, doi. 10.1038/s41416-024-02789-2
    By:
    • van der Kleij, Maud B. A.;
    • Guchelaar, Niels A. D.;
    • Meertens, Marinda;
    • Westerdijk, Kim;
    • Giraud, Eline L.;
    • Bleckman, Roos F.;
    • Groenland, Stefanie L.;
    • van Eerden, Ruben A. G.;
    • Imholz, Alex L. T.;
    • Vulink, Annelie J. E.;
    • Otten, Hans-Martin;
    • Fiebrich-Westra, Helle-Brit;
    • Lubberman, Floor J. E.;
    • Desar, Ingrid M. E.;
    • Moes, Dirk-Jan A. R.;
    • Touw, Daan J.;
    • Koolen, Stijn L. W.;
    • Gelderblom, Hans;
    • Reyners, An K. L.;
    • van Erp, Nielka P.
    Publication type:
    Article
    7
    8
    9

    Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC).

    Published in:
    Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1136221
    By:
    • Meertens, Marinda;
    • Muntinghe-Wagenaar, M. Benthe;
    • Sikkema, Barend J.;
    • Lopez-Yurda, Marta;
    • Retèl, Valesca P.;
    • Paats, Marthe S.;
    • Heine, Rob Ter;
    • Schuuring, Ed;
    • Timens, Wim;
    • Touw, Daan J.;
    • van Boven, Job F. M.;
    • de Langen, Adrianus. J.;
    • Hashemi, Sayed M. S.;
    • Hendriks, Lizza E. L.;
    • Croes, Sander;
    • van den Heuvel, Michel M.;
    • Dingemans, Anne-Marie C.;
    • Mathijssen, Ron H. J.;
    • Smit, Egbert F.;
    • Huitema, Alwin D. R.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Managing intoxications with nicotine-containing e-liquids.

    Published in:
    Expert Opinion on Drug Metabolism & Toxicology, 2022, v. 18, n. 2, p. 115, doi. 10.1080/17425255.2022.2058930
    By:
    • Henstra, Charlotte;
    • Dekkers, Bart G. J.;
    • Olgers, Tycho J.;
    • ter Maaten, Jan C.;
    • Touw, Daan J.
    Publication type:
    Article
    20
    21
    22
    23
    24
    25

    SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin.

    Published in:
    Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.1042989
    By:
    • Hurkmans, Evelien G. E.;
    • Koenderink, Jan B.;
    • van den Heuvel, Jeroen J. M. W.;
    • Versleijen-Jonkers, Yvonne M. H.;
    • Hillebrandt-Roeffen, Melissa H. S.;
    • Groothuismink, Johanne M.;
    • Vos, Hanneke I.;
    • van der Graaf, Winette T. A.;
    • Flucke, Uta;
    • Muradjan, Grigor;
    • Schreuder, Hendrik W. B.;
    • Hagleitner, Melanie M.;
    • Brunner, Han G.;
    • Gelderblom, Hans;
    • Cleton-Jansen, Anne-Marie;
    • Guchelaar, Henk-Jan;
    • de Bont, Eveline S. J. M.;
    • Touw, Daan J.;
    • Nijhoff, G. Jan;
    • Kremer, Leontien C. M.
    Publication type:
    Article
    26
    27
    28

    Pharmacomicrobiomics: a novel route towards personalized medicine?

    Published in:
    Protein & Cell, 2018, v. 9, n. 5, p. 432, doi. 10.1007/s13238-018-0547-2
    By:
    • Doestzada, Marwah;
    • Vila, Arnau Vich;
    • Zhernakova, Alexandra;
    • Koonen, Debby P. Y.;
    • Weersma, Rinse K.;
    • Touw, Daan J.;
    • Kuipers, Folkert;
    • Wijmenga, Cisca;
    • Fu, Jingyuan
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Authors' reply to amanita intoxication.

    Published in:
    Clinical Toxicology (15563650), 2023, v. 61, n. 5, p. 411, doi. 10.1080/15563650.2023.2206944
    By:
    • Dekkers, Bart G. J.;
    • Touw, Daan J.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50